Validation of the UFS-QOL-Hysterectomy Questionnaire: Modifying an Existing Measure for Comparative Effectiveness Research

Coyne, Karin S.; Margolis, Mary Kay; Murphy, Jeanne; Spies, James B.

doi:10.1016/j.jval.2012.03.1387

Cited by 39 publications

(33 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a prospective, cross-sectional study of women's health-related QOL, Leong et al [11] found women experienced poor emotional role functioning and negative impacts on mental health while awaiting surgery for pelvic organ prolapse. In a study that examined QOL among women who underwent hysterectomy, improvements were noted in symptom severity and 8 QOL domains (concern, activities, energy/mood, control, self-consciousness, and sexual function) at 1-year compared with baseline [20]. Taken together, these findings suggest that increased surgical wait times before hysterectomy for benign indications may adversely affect patient well-being and should be minimized, always taking into account patient safety and optimizing any comorbid medical conditions where appropriate.…”

Section: Discussionmentioning

confidence: 99%

Impact of Surgical Wait Time to Hysterectomy for Benign Gynecologic Disease

Traylor

Koelper

Kim

et al. 2021

Journal of Minimally Invasive Gynecology

View full text Add to dashboard Cite

To determine the impact of surgical wait time on healthcare use and surgical outcomes for patients undergoing hysterectomy for benign gynecologic indications. Design: Retrospective cohort study. Setting: Urban, academic tertiary care center. Patients: Patients who underwent hysterectomy for benign disease between 2012 and 2018. Interventions: None. Measurements and Main Results: Patients were categorized into 2 groups, dichotomized by surgical wait times >30 days or ≤30 days. Healthcare use was measured by the number of discrete patient interactions with the healthcare system through phone calls, secure electronic messaging, and office and emergency room visits. Univariate and multivariable logistic regression models were performed to assess the association between surgical wait time and healthcare use and perioperative outcomes while controlling for confounders. A total of 277 patients were included in our analysis: 106 (38.3%) had surgical wait times >30 days (median 47 days, range 24−68 days), and 171 (67.1%) had surgical wait times ≤30 days (median 19 days; range 12−26 days). The groups did not differ by age, insurance status, substance use, or comorbid conditions. Patients in the group with surgical wait times >30 days were more likely to have increased healthcare use (69 of 106, 65% vs 43 of 171, 25%; odds ratio 5.55; 95% confidence interval, 3.27−9.41). There were no differences in intraoperative complications (9 of 106, 8% vs 19 of 171, 11%; p = .482) or postoperative complications (28 of 106, 26% vs 32 of 171, 19%; p = .13) between the groups; however, after controlling for potential confounders, patients with surgical wait times >30 days were 3.22 times more likely to be readmitted than patients with surgical wait times ≤30 days (95% confidence interval, 1.27−8.19). Conclusion: A surgical wait time >30 days in patients undergoing a hysterectomy for benign disease is associated with increased healthcare use in the interim. Although patients who experience longer surgical wait times do not experience worse surgical outcomes, they may be at higher risk for readmission after surgery. Targeted interventions to optimize perioperative coordination of care for patients undergoing a hysterectomy for benign disease, especially those within vulnerable populations, are needed to improve quality of care, decrease any redundant or inefficient healthcare use, and reduce any unnecessary delays.

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of Surgical Wait Time to Hysterectomy for Benign Gynecologic Disease

Traylor

Koelper

Kim

et al. 2021

Journal of Minimally Invasive Gynecology

View full text Add to dashboard Cite

show abstract

“…The 2008 FIBROID registry, which involved 3160 UAE patients from 72 sites, found relatively low rates of reintervention. At 3 years of follow-up in 1278 patients, further treatment with hysterectomy, myomectomy, or repeat UAE was estimated to be 9.79%, 2.82%, and 1.83%, respectively (88). Similarly, further treatment was required in 10.5% of 200 patients (92) and 6% of 400 patients (93) in other studies.…”

Section: Discussionmentioning

confidence: 90%

“…A fibroid-specific self-administered uterine fibroid symptom and quality of life (UFS-QoL) questionnaire has been developed to assess symptom resolution and quality of life, including a menorrhagia questionnaire and sexual function scale (87). Its initial development and validation showed the ability of this questionnaire to discriminate between UAE patients and normal volunteers as well as between UAE patients with different outcomes and has proved to very important in the assessment of quality of life after UAE and for the FIBROID registry (87)(88)(89).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Management of Uterine Fibroids: A Focus on Uterine-sparing Interventional Techniques

Silberzweig¹,

Powell²,

Matsumoto³

et al. 2016

Radiology

View full text Add to dashboard Cite

Uterine fibroids occur in approximately 50% of women over the age of 40 years, and an estimated 50% of those are symptomatic. Menorrhagia is the most common symptom and the primary indication for treatment, although bulk symptoms often occur and can be treated. Pharmacotherapy is typically inadequate unless it can be expected to successfully bridge to menopause or allow for a less-invasive intervention. However, hormonal therapies have risks. Hysterectomy is still the most commonly performed procedure for symptomatic fibroids and has the lowest rate of reintervention (compared with myomectomy or uterine artery embolization [UAE]), but rates of more serious complications are higher and patient satisfaction and ability to return to normal activities may also be less favorable. Myomectomy is not necessarily less morbid than hysterectomy and may have a greater failure rate than UAE. Techniques and devices vary with little standardization, and operator experience is crucial to success. The largest studies of UAE show very low rates of serious complications and rapid recovery. UAE significantly improves symptoms related to uterine fibroids in 85%-90% of patients. Herein, this article will discuss the nature of fibroids and their diagnosis, pharmacotherapy, surgical treatment, and nonsurgical interventional treatment, including UAE and magnetic resonance-guided focused ultrasound. (©) RSNA, 2016.

show abstract

“…15 Recently, the questionnaire was slightly modified for women who have undergone hysterectomy. 16 Some non-English-speaking countries have used this questionnaire for studies on women with UF without validating it, such as a study conducted in Korea. 17 This study presented some limitations: we did not calculate the criterion validity, which would consist of assessment of the UFS-QOL questionnaire using a clinical tool that is considered to be the gold standard.…”

Section: Discussionmentioning

confidence: 99%

Translation and validation of the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire for the Brazilian Portuguese language

et al. 2017

View full text Add to dashboard Cite

CONTEXT AND OBJECTIVE: Uterine fibroids (UF), also known as leiomyomas, are the most prevalent gynecological tumors. The Uterine Fibroid Symptoms and Quality of Life (UFS-QOL) is the only specific questionnaire that assesses symptom intensity and quality-of-life issues for women with symptomatic UF; however, it only exists in the English language. Thus, we aimed to translate and culturally validate the UFS-QOL questionnaire for the Brazilian Portuguese language. DESIGN AND SETTING: Cross-sectional study, Department of Gynecology and Obstetrics, FMRP-USP. METHODS: 113 patients with UF (case group) and 55 patients without UF (control group) were interviewed using the UFS-QOL questionnaire after translation and cultural adaptation. The Short Form-36 questionnaire was used as a control. Demographic and psychometric variables were analyzed. RESULTS: Women with UF presented higher mean age, body mass index, weight, parity and comorbidities than the control group (P < 0.05). The most prevalent complaints were abnormal uterine bleeding (93.8%), pelvic pain (36.3%) and extrinsic compression (10.6%) and these presented adequate construct validity regarding UFS-QOL severity (P < 0.05). The UFS-QOL questionnaire presented good internal consistency regarding symptom severity and quality-of-life-related domains (intraclass correlation coefficient, ICC = 0.82/0.88). Structural validity presented correlation coefficients ranging from 0.59 to 0.91.

show abstract

Validation of the UFS-QOL-Hysterectomy Questionnaire: Modifying an Existing Measure for Comparative Effectiveness Research

Abstract: The UFS-QOL-Hysterectomy questionnaire is a valid and reliable patient-reported outcome measure of uterine fibroid treatment with hysterectomy and can be used in conjunction with the UFS-QOL questionnaire to compare patient-reported outcomes across treatments.

Cited by 39 publications

References 13 publications

Impact of Surgical Wait Time to Hysterectomy for Benign Gynecologic Disease

Impact of Surgical Wait Time to Hysterectomy for Benign Gynecologic Disease

Management of Uterine Fibroids: A Focus on Uterine-sparing Interventional Techniques

Translation and validation of the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire for the Brazilian Portuguese language

Contact Info

Product

Resources

About